Alpha enolase is a cytoplasmic glycolytic enzyme (Chang et al, 2003) and is downregulated in non-small-cell lung carcinoma, and so the upregulation of this protein with Gefitinib could play a part in the reversal of tumorigenesis. The gene discussed is ENO1; the disease is non-small cell lung carcinoma.